James A Watson, MD
Obstetrics/Gynecology · Gilroy
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 33
- 9 carriers
- Offices
- 2
Offices
2 locations
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
33 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Watson’s office at (408) 842-6500 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A98977 · Current
Licensed to practise in California · since 2007 · expires 2027-01-31 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$12,005
Medicare paid this office $12,005 for 75 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 43 | $4,168 | $73 |
| New patient visit (30+ min) | 24 | $2,029 | $85 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 16 | $1,932 | $121 |
Who their Medicare patients are
75 Original Medicare patients in 2024. Average age 71 · Women 100% · Also on Medicaid 16% · Health risk score 0.87. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 60% · Diabetes 31% · Depression 23% · Coronary heart disease 17%.
The office billed $42,629, Medicare allowed $17,327 and paid $12,005; for 122 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 75 | 122 | 71 | 0.87 | $42,629 | $12,005 |
| 2023 | 70 | 131 | 71 | 0.94 | $47,594 | $14,363 |
| 2022 | 81 | 164 | 70 | 0.85 | $65,103 | $20,276 |
| 2021 | 77 | 146 | 70 | 0.89 | $60,634 | $17,957 |
| 2020 | 62 | 120 | 70 | 0.84 | $34,774 | $9,842 |
| 2019 | 88 | 205 | 68 | 0.94 | $57,690 | $16,558 |
| 2018 | 90 | 181 | 70 | 1.00 | $56,004 | $15,188 |
| 2017 | 122 | 256 | 68 | 0.98 | $78,524 | $20,913 |
| 2016 | 164 | 314 | 69 | 0.94 | $107,984 | $29,170 |
| 2015 | 102 | 205 | 69 | 0.94 | $83,710 | $23,104 |
| 2014 | 84 | 199 | 68 | 1.18 | $57,731 | $21,779 |
| 2013 | 81 | 166 | 68 | 0.90 | $57,225 | $18,757 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Short return visit (20+ min) | 32 | $3,597 | $73 |
| New patient visit (45+ min) | 16 | $2,460 | $154 |
| New patient visit (30+ min) | 25 | $2,421 | $97 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 16 | $2,191 | $115 |
2022: 4 services
| Short return visit (20+ min) | 40 | $4,529 | $74 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 17 | $2,280 | $127 |
| New patient visit (45+ min) | 17 | $2,088 | $123 |
| New patient visit (30+ min) | 23 | $2,072 | $90 |
2021: 4 services
| Short return visit (20+ min) | 35 | $4,390 | $83 |
| New patient visit (45+ min) | 23 | $2,944 | $128 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 14 | $1,870 | $134 |
| New patient visit (30+ min) | 13 | $1,249 | $96 |
2020: 3 services
| Short return visit (20+ min) | 30 | $2,949 | $56 |
| New patient visit (45+ min) | 20 | $2,890 | $144 |
| Return visit (30+ min) | 11 | $1,051 | $96 |
2019: 6 services
| Short return visit (20+ min) | 46 | $4,349 | $61 |
| New patient visit (45+ min) | 20 | $2,460 | $123 |
| Return visit (30+ min) | 23 | $1,760 | $77 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 33 | $1,537 | $47 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 11 | $1,457 | $121 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 21 | $1,132 | $54 |
2018: 5 services
| Short return visit (20+ min) | 56 | $5,064 | $60 |
| New patient visit (45+ min) | 16 | $2,170 | $136 |
| Return visit (30+ min) | 20 | $1,913 | $87 |
| New patient visit (30+ min) | 12 | $1,084 | $90 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 11 | $486 | $44 |
2017: 7 services
| Short return visit (20+ min) | 59 | $4,996 | $59 |
| New patient visit (45+ min) | 40 | $4,220 | $105 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 17 | $2,395 | $120 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 39 | $1,733 | $44 |
| New patient visit (30+ min) | 18 | $1,561 | $87 |
| Return visit (30+ min) | 13 | $1,278 | $85 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 19 | $1,024 | $54 |
2016: 7 services
| New patient visit (45+ min) | 79 | $10,856 | $137 |
| Short return visit (20+ min) | 55 | $4,156 | $60 |
| New patient visit (30+ min) | 33 | $2,924 | $89 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 64 | $2,900 | $45 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 14 | $1,743 | $125 |
| Return visit (30+ min) | 14 | $1,309 | $93 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 16 | $886 | $55 |
2015: 7 services
| New patient visit (45+ min) | 48 | $6,336 | $132 |
| Short return visit (20+ min) | 29 | $2,545 | $64 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 15 | $1,728 | $115 |
| New patient visit (30+ min) | 19 | $1,599 | $84 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 33 | $1,498 | $45 |
| Return visit (30+ min) | 13 | $1,271 | $91 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 15 | $832 | $55 |
2014: 6 services
| New patient visit (45+ min) | 34 | $4,533 | $133 |
| Short return visit (20+ min) | 38 | $3,086 | $64 |
| New patient visit (30+ min) | 20 | $1,991 | $100 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 15 | $1,913 | $128 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 28 | $1,258 | $45 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 11 | $601 | $55 |
2013: 5 services
| New patient visit (45+ min) | 32 | $4,548 | $142 |
| Short return visit (20+ min) | 38 | $2,656 | $59 |
| New patient visit (30+ min) | 16 | $1,257 | $79 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 21 | $954 | $45 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 11 | $821 | $75 |
Medicaid work
$342 in 2024
Medicaid paid $342 for 155 billed services this clinician did in 2024, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| FETAL NON-STRESS TEST | 19 | $342 |
| Ultrasound by transvaginal approach | 12 | $0 |
| Short return visit (20+ min) | 124 | $0 |
| 2024 | 155 | 3 | 24 | $342 |
| 2023 | 174 | 4 | 17 | $142 |
| 2022 | 147 | 4 | 16 | $0 |
| 2021 | 432 | 7 | 19 | $69 |
| 2020 | 287 | 2 | 20 | $79 |
| 2019 | 450 | 4 | 23 | $0 |
| 2018 | 139 | 2 | 21 | $0 |
See the largest Medicaid services in earlier years
2023
| FETAL NON-STRESS TEST | 14 | $142 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 60 | $0 |
| Ultrasound by transvaginal approach | 24 | $0 |
| Short return visit (20+ min) | 76 | $0 |
2022
| ANTEPARTUM CARE ONLY 4-6 VISITS | 33 | $0 |
| Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses | 43 | $0 |
| Ultrasound by transvaginal approach | 29 | $0 |
| Short return visit (20+ min) | 42 | $0 |
2021
| New patient visit (45+ min) | 12 | $69 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 141 | $0 |
| Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses | 13 | $0 |
| Ultrasound by transvaginal approach | 78 | $0 |
| Short return visit (20+ min) | 147 | $0 |
| Return visit (30+ min) | 24 | $0 |
| Prenatal care, at-risk enhanced service; antepartum management | 17 | $0 |
2020
| Short return visit (20+ min) | 42 | $79 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 245 | $0 |
2019
| ANTEPARTUM CARE ONLY 4-6 VISITS | 365 | $0 |
| Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses | 15 | $0 |
| Short return visit (20+ min) | 54 | $0 |
| Return visit (30+ min) | 16 | $0 |
2018
| ANTEPARTUM CARE ONLY 4-6 VISITS | 125 | $0 |
| Short return visit (20+ min) | 14 | $0 |
Drugs they prescribed that Part D paid
$10,059
Pharmacies billed $10,059 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
117 generic and 17 brand-name prescriptions · $10,059 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 21 | $571 | $27 |
| Alendronate | 20 | $159 | $8 |
| Sertraline | 12 | $12 | $1 |
Year by year
| 2024 | 134 | 46 | None | 13% | $10,059 |
| 2023 | 103 | 43 | None | 17% | $9,128 |
| 2022 | 92 | 40 | None | 23% | $16,418 |
| 2021 | 99 | 37 | None | 14% | $9,733 |
| 2020 | 147 | 50 | None | 12% | $14,220 |
| 2019 | 160 | 50 | 0% (0) | 16% | $18,113 |
| 2018 | 135 | 50 | None | 16% | $16,203 |
| 2017 | 201 | 46 | None | 24% | $23,264 |
| 2016 | 170 | 49 | None | 21% | $14,505 |
| 2015 | 159 | 44 | None | 25% | $13,452 |
| 2014 | 153 | 38 | None | 27% | $9,663 |
| 2013 | 120 | 24 | 13% (16) | 22% | $4,876 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Premarin | 11 | $3,029 | $275 |
| Estradiol | 22 | $1,420 | $65 |
| Alendronate | 15 | $144 | $10 |
2022: 3 drugs
| Premarin | 12 | $5,813 | $484 |
| Estradiol | 22 | $2,106 | $96 |
| Alendronate | 13 | $138 | $11 |
2021: 3 drugs
| Estradiol | 20 | $2,004 | $100 |
| Junel Fe | 14 | $315 | $22 |
| Alendronate | 11 | $136 | $12 |
2020: 3 drugs
| Estradiol | 26 | $3,567 | $137 |
| Alendronate | 19 | $181 | $10 |
| Ibuprofen | 12 | $144 | $12 |
2019: 2 drugs
| Estradiol | 48 | $8,054 | $168 |
| Alendronate | 22 | $100 | $5 |
2018: 2 drugs
| Estradiol | 37 | $5,890 | $159 |
| Alendronate | 22 | $123 | $6 |
2017: 4 drugs
| Estrace | 25 | $7,257 | $290 |
| Premarin | 12 | $4,762 | $397 |
| Estradiol | 21 | $815 | $39 |
| Alendronate | 21 | $151 | $7 |
2016: 4 drugs
| Premarin | 14 | $4,196 | $300 |
| Imipramine | 12 | $817 | $68 |
| Estradiol | 11 | $310 | $28 |
| Alendronate | 33 | $187 | $6 |
2015: 4 drugs
| Premarin | 21 | $5,060 | $241 |
| Clobetasol Propionate | 14 | $2,580 | $184 |
| Imipramine | 12 | $469 | $39 |
| Alendronate | 37 | $260 | $7 |
2014: 3 drugs
| Premarin | 15 | $3,245 | $216 |
| Polyethylene Glycol 3350 | 12 | $377 | $31 |
| Alendronate | 23 | $149 | $6 |
2013: 2 drugs
| Premarin | 12 | $2,462 | $205 |
| Alendronate | 13 | $86 | $7 |
Money from drug and device companies
$99 in 2025
| 2025 | 3 | 4 | None | $99 |
| 2024 | 3 | 5 | None | $106 |
| 2023 | 3 | 4 | None | $76 |
| 2022 | 5 | 21 | None | $328 |
| 2021 | 6 | 18 | None | $318 |
| 2020 | 3 | 8 | None | $204 |
| 2019 | 3 | 3 | None | $45 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Organon | Nexplanon | $55 | 2 payments
|
| Sumitomo Pharma America | Gemtesa | $30 | 1 payment
|
| CooperSurgical | Paragard T 380a | $14 | 1 payment
|
See all 4 published payments
| Organon | Meals · 2025-11-06 | Nexplanon | $32 |
| Sumitomo Pharma America | Meals · 2025-07-30 | Gemtesa | $30 |
| Organon | Meals · 2025-03-27 | Nexplanon | $24 |
| CooperSurgical | Meals · 2025-02-11 | Paragard T 380a | $14 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $106
| Pfizer | Nurtec Odt | $60 | 3 payments
|
| Organon | Nexplanon | $23 | 1 payment
|
| Baxter Healthcare | Perclot | $23 | 1 payment
|
2023: $76
| Mayne Pharma Commercial | None | $30 | 2 payments
|
| Ethicon US | Ethicon | $24 | 1 payment
|
| Organon | Nexplanon | $22 | 1 payment
|
2022: $328
| Mayne Pharma | None | $113 | 11 payments
|
| Organon | Nexplanon | $77 | 4 payments
|
| Pfizer | Myfembree | $53 | 3 payments
|
| Abbvie | Lo Loestrin Fe | $47 | 2 payments
|
| Ethicon US | Megadyne | $39 | 1 payment
|
2021: $318
| AbbVie | Lo Loestrin Fe | $170 | 10 payments
|
| Pfizer | Premarin | $79 | 3 payments
|
| TherapeuticsMD | Annovera | $35 | 2 payments
|
| Roche Diagnostics | Cintec Plus Cytology | $17 | 1 payment
|
| Myovant Sciences | Myfembree | $12 | 1 payment
|
| Organon | Nexplanon | $5 | 1 payment
|
2020: $204
| Pfizer | Premarin | $112 | 4 payments
|
| AbbVie | Liletta | $71 | 3 payments
|
| Merck Sharp & Dohme | None | $20 | 1 payment
|
2019: $45
| Roche Diagnostics | Rs Harmony Test Related Products | $17 | 1 payment
|
| Allergan | Lo Loestrin Fe | $15 | 1 payment
|
| AMAG Pharmaceuticals | Intrarosa | $13 | 1 payment
|
Professional record
- NPI
- 1780705665
- Licence
- CA A98977California A98977: Current · expires 2027-01-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 174400000X (174400000X)
- Mailing address
- 8833 Monterey Rd, Ste G, Gilroy, CA, 95020
- NPI first listed
- 2007-04-02
- NPI last updated
- 2018-03-16
This is when the NPI record was last certified, not a medical board exam.